| Literature DB >> 34379602 |
Robert P Hirten1,2, Matteo Danieletto2, Lewis Tomalin3, Katie Hyewon Choi3, Micol Zweig2, Eddye Golden2, Sparshdeep Kaur2, Drew Helmus1, Anthony Biello1, Renata Pyzik4, Claudia Calcagno4, Robert Freeman5, Bruce E Sands1, Dennis Charney6,7, Erwin P Bottinger2, James W Murrough7,8, Laurie Keefer1, Mayte Suarez-Farinas3, Girish N Nadkarni2,9, Zahi A Fayad4.
Abstract
BACKGROUND: The COVID-19 pandemic has resulted in a high degree of psychological distress among health care workers (HCWs). There is a need to characterize which HCWs are at an increased risk of developing psychological effects from the pandemic. Given the differences in the response of individuals to stress, an analysis of both the perceived and physiological consequences of stressors can provide a comprehensive evaluation of its impact.Entities:
Keywords: COVID-19; app; emotion; health care worker; heart rate; heart rate variability; mental health; nervous system; observational; physiology; psychological; psychology; quality of life; resilience; stress; support; wearable device
Mesh:
Year: 2021 PMID: 34379602 PMCID: PMC8439178 DOI: 10.2196/31295
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Baseline demographic characteristics of the total cohort and by occupation category.
| Characteristic | Total cohort (N=361) | Staff (n=65) | Clinical nontrainee (n=217) | Clinical trainee (n=40) | ||||||||
| Age (years), mean (SD) | 36.8 (10.1) | 36.5 (11.0) | 37.8 (10.4) | 31.1 (3.6) | ||||||||
| BMI, mean (SD) | 25.7 (5.8) | —a | — | — | ||||||||
| Female gender, n (%) | 246 (69.3) | 43 (66.2) | 158 (73.8) | 20 (51.3) | ||||||||
|
|
|
|
| |||||||||
|
| Asian | 90 (24.9) | 14 (21.5) | 49 (22.6) | 14 (35.0) | |||||||
|
| Black | 33 (9.1) | 3 (4.6) | 23 (10.6) | 4 (10.0) | |||||||
|
| White | 132 (36.6) | 26 (40.0) | 80 (36.9) | 15 (37.5) | |||||||
|
| Other | 47 (13.0) | 7 (10.8) | 31 (14.3) | 6 (15.0) | |||||||
|
|
|
|
| |||||||||
|
| Hispanic | 59 (16.3) | 15 (23.1) | 34 (15.7) | 1 (2.5) | |||||||
| Baseline positive SARS-CoV-2 nasal PCR,b n (%) | 22 (6.1) | 2 (3.1) | 16 (7.4) | 2 (5.0) | ||||||||
| Baseline positive SARS-CoV-2 serum antibody, n (%) | 35 (9.7) | 6 (9.2) | 22 (10.1) | 2 (5.0) | ||||||||
|
|
|
|
| |||||||||
|
| Current/past smoker | 48 (13.5) | 10 (15.4) | 31 (14.5) | 0 (0.0) | |||||||
|
| Never/rarely smoked | 307 (86.5) | 55 (84.6) | 183 (85.5) | 39 (100.0) | |||||||
| Baseline immune-suppressing medication, n (%) | 4 (1.4) | 0 (0.0) | 4 (1.9) | 0 (0.0) | ||||||||
| Anxiety or depression, n (%) | 73 (20.6) | 16 (24.6) | 43 (20.1) | 7 (17.9) | ||||||||
|
|
|
|
| |||||||||
|
| Perceived Stress Scale-4 | 5.3 (3.1) | 5.3 (3.1) | 5.5 (2.9) | 5.4 (3.1) | |||||||
|
| Connor-Davidson Resilience Scale-2 | 5.7 (1.4) | 5.4 (1.5) | 5.7 (1.4) | 6.2 (1.3) | |||||||
|
| Optimism | 19.1 (4.2) | 18.4 (4.3) | 18.8 (4.2) | 20.1 (3.7) | |||||||
|
| Emotional support | 6.8 (1.5) | 6.7 (1.7) | 6.8 (1.5) | 7.6 (0.9) | |||||||
|
| Quality of life | 7.8 (1.5) | 7.5 (1.4) | 7.8 (1.4) | 8.0 (1.5) | |||||||
|
|
|
|
| |||||||||
|
| Asthma | 41 (11.4) | 13 (20) | 19 (8.8) | 5 (12.5) | |||||||
|
| Chronic lung disease | 1 (0.3) | 0 (0.0) | 0 (0.0) | 1 (2.5) | |||||||
|
| Heart disease | 1 (0.3) | 1 (1.5) | 0 (0.0) | 0 (0.0) | |||||||
|
| Cancer | 2 (0.6) | 0 (0.0) | 2 (0.9) | 0 (0.0) | |||||||
|
| Diabetes mellitus | 6 (1.7) | 2 (3.1) | 4 (1.8) | 0 (0.0) | |||||||
|
| Hypertension | 20 (5.5) | 5 (7.7) | 11 (5.1) | 0 (0.0) | |||||||
|
| Pneumonia | 7 (1.9) | 1 (1.5) | 5 (2.3) | 1 (2.5) | |||||||
aNot applicable.
bPCR: polymerase chain reaction.
Univariate analysis of factors associated with longitudinal perceived stress.
| Factor | Effect estimate | |
| Baseline resilience | –0.84 | <.001 |
| Baseline optimism | –0.34 | <.001 |
| Baseline emotional support | –0.62 | <.001 |
| Baseline quality of life | –0.71 | <.001 |
| Longitudinal quality of life | –0.80 | <.001 |
| Baseline anxiety or depression | 1.27 | <.001 |
| Baseline BMI | 0.07 | .001 |
| Male gender | –0.94 | .002 |
| Mean New York City case count per period | 0.82 | .004 |
| No positive COVID-19 nasal PCRa at baseline | 0.91 | .11 |
| 2 weeks post positive COVID-19 nasal PCR test | –0.18 | .62 |
| 4 weeks post positive COVID-19 nasal PCR test | –0.82 | .01 |
| 2 weeks post positive COVID-19 antibody test | –0.36 | .19 |
| 4 weeks post positive COVID-19 antibody test | –0.10 | .71 |
| Any period post positive COVID-19 nasal PCR test | –0.85 | .04 |
| 2 weeks post positive COVID-19 PCR or antibody test | –0.25 | .28 |
| Any period post positive COVID-19 antibody test | –0.26 | .36 |
| Weight | 0.02 | .04 |
| Age | –0.03 | .047 |
| Baseline asthma | 0.89 | .045 |
| Baseline heart disease | 3.37 | .19 |
| Baseline hypertension | –0.34 | .58 |
| Baseline diabetes | –0.20 | .85 |
| Mean symptomatic days per period | 0.32 | .07 |
| Staff vs clinical nontrainee | –0.03 | .81 |
| Staff vs clinical trainee | 0.43 | .15 |
| Clinical vs clinical trainee | 0.60 | .17 |
| Any period post positive COVID-19 PCR or antibody test | –0.47 | .07 |
| Height | –0.03 | .08 |
| Mean days traveled per period | –0.09 | .58 |
| Days left home per period | –0.05 | .08 |
| No immune-suppressing medication at baseline | –1.80 | .17 |
| No childcare needs at baseline | –0.39 | .23 |
| Smoking at baseline | 0.53 | .20 |
| Mean days hospitalized per period | –1.66 | .27 |
| Mean days treating COVID-19–positive patients per period | 0.22 | .28 |
| Number of days left home | –0.02 | .30 |
| Asian vs Black | 0.02 | .97 |
| Asian vs other | –0.34 | .47 |
| Black vs other | –0.36 | .55 |
| White vs Asian | 0.01 | .99 |
| White vs Black | 0.03 | .96 |
| White vs other | –0.34 | .45 |
| No positive COVID-19 antibody test at baseline | 0.03 | .69 |
| Days caring for patients with COVID-19 | 0.01 | .73 |
| Interacted with 1-3 people outside the home per day | 0.01 | .97 |
| Interacted with 4-9 people outside the home per day | 0.01 | .96 |
| Interacted with ≥10 people outside the home per day | –0.11 | .64 |
| Mean days quarantined per period | –0.20 | .80 |
| Total symptomatic days per period | 0.01 | .85 |
| Days working weighted based on patient exposure | 0.03 | .69 |
| Days hospitalized per period | 0.07 | .88 |
| Days quarantined per period | –0.03 | .90 |
| Mean number of days the participant left the house per period | 0.03 | .90 |
| Mean working days during this period | 0.02 | .88 |
| Sum of the severity of COVID-19 symptoms per period | –0.001 | .96 |
| Mean severity of COVID-19 symptoms this period | 0.08 | .14 |
aPCR: polymerase chain reaction.
Figure 1Multivariate analysis of factors associated with longitudinal stress. The scatter plot shows estimated coefficients (CIs) for variables used in the multivariate analysis. Stars indicate that the variable has a significant (P<.05) association with longitudinal stress while crosses indicate a borderline significant relationship (P<.10). Positive association is indicated in blue and negative association in red. NYC: New York City; PCR: polymerase chain reaction.
Figure 2Exploring the relationship between heart rate variability (HRV), emotional support, and resilience. Plots A and C show mean (95% CIs) HRV midline statistic of rhythm (MESOR), amplitude, and acrophase for participants with low, medium, and high emotional support (A) or resilience (C). Stars indicate significant differences between groups. Plots B and D show average daily circadian HRV rhythm for participants with low, medium, and high emotional support (B) or resilience (D). +P<.10, *P<.05, **P<.01, ***P<.001. SDNN: standard deviation of NN intervals.
Comparison of mean heart rate variability parameters stratified based on emotional support and resilience tertials.
| Parameter and tertial comparisons | Emotional support, | Resilience, | |||
|
| |||||
|
| Low vs medium | .60 | .10 | ||
|
| Low vs high | .67 | .46 | ||
|
| Medium vs high | .78 | .71 | ||
|
| |||||
|
| Low vs medium | .68 | <.001 | ||
|
| Low vs high | .01 | <.001 | ||
|
| Medium vs high | <.001 | .24 | ||
|
| |||||
|
| Low vs medium | .70 | .09 | ||
|
| Low vs high | .004 | .048 | ||
|
| Medium vs high | <.001 | <.001 | ||
aMESOR: midline statistic of rhythm.